Contract Number: 75f40119c10108
The FDA plans to acquire licenses and services from Synchrogenix Information Strategies Inc. This includes activities required for maintaining and supporting the Global Submit Review and GlobalSubmit Validate software.
The software is being used by reviewers in the CDER and CBER.
The contract value is $1.86M.
